Reviews Getfitinib


No reviews yet.

Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008




Iressa Drug Description
IRESSA®
(gefitinib) Tablets, 250 mg
DRUG DESCRIPTION



What are the possible side effects of gefitinib (Iressa)?

If you experience any of the following serious side effects from gefitinib, contact your doctor immediately:

an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);
lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);
severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or
eye pain or irritation.

Other, less serious...
Read All Potential Side Effects for Iressa »




IRESSA® (gefitinib tablets) contain 250 mg of gefitinib and
are available as brown film-coated tablets for daily oral administration.
Gefitinib is an anilinoquinazoline with the chemical name 4-Quinazolinamine,
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-4-morpholin) propoxy] and
the following structural formula:








It has the molecular formula C22H24ClFN4O3,
a relative molecular mass of 446.9 and is a white-colored powder. Gefitinib
is a free base. The molecule has pKas of 5.4 and 7.2 and therefore
ionizes progressively in solution as the pH falls. Gefitinib can be defined
as sparingly soluble at pH 1, but is practically insoluble above pH 7, with
the solubility dropping sharply between pH 4 and pH 6. In non-aqueous solvents,
gefitinib is freely soluble in glacial acetic acid and dimethylsulphoxide, soluble
in pyridine, sparingly soluble in tetrahydrofuran, and slightly soluble in methanol,
ethanol (99.5%), ethyl acetate, propan-2-ol and acetonitrile.
The inactive ingredients of IRESSA tablets are: Tablet core: Lactose
monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium
lauryl sulfate and magnesium stearate. Coating: Hypromellose, polyethylene
glycol 300, titanium dioxide, red ferric oxide and yellow ferric oxide.Last reviewed on RxList: 10/2/2008





Other reviews about Getfitinib on web:

Gefitinib (pronounced /ɡɛˈfɪtɨnɪb/) (Iressa) is a drug used in the treatment of certain types of cancer. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts ... Gefitinib - Wikipedia, the free encyclopedia


Gefitinib Definition Gefitinib, which is also known as Iressa, is an anti-cancer drug used to inhibit the growth of lung cancer cells and reduce the Gefitinib: Information from Answers.com


This page contains brief information about gefitinib and a collection of links to more information about the use of this drug, related news and research results, and ongoing ... Gefitinib - National Cancer Institute


All about Gefitinib. View complete and up to date Gefitinib information - part of the Drugs.com trusted medication database. Gefitinib Facts and Comparisons at Drugs.com


Gefitinib is not a chemotherapeutic in the traditional sense, since it does not cause the destruction of tumor cells. Instead, gefitnib interferes with the growth and spread of new ... Gefitinib


Gefitinib is a targeted therapy. It is classified as a signal transduction inhibitor (epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor). Iressa Gefitinib, Iressa - Chemotherapy Drugs, Chemo Drug Side Effects


Exposes the medication gefitinib (Iressa), a drug used as monotherapy for lung cancer that has not responded to chemotherapy. gefitinib (Iressa) - drug class, medical uses, medication side ...


Learn more about Gefitinib. Find the Web's best health guides, medical reports, news, videos and tools for Gefitinib. Share Gefitinib experiences and get advice from experts. Gefitinib Overview - References, Advice, News, Videos, Coping ...


Physician reviewed gefitinib patient information - includes gefitinib description, dosage and directions. gefitinib medical facts from Drugs.com


Why It Is Prescribed. Gefitinib is used to treat non-small cell lung cancer in people who have already been treated with certain other chemotherapy medications and have not improved ... Gefitinib - Kosmix : Reference, Videos, Images, News, Shopping and ...





Featured Reviews

Reviews Pseudovent 400 Capsules

Pseudovent 400 Capsules Drug Description Pseudovent™ 400 (pseudoephedrine HCl [extended-release]/ guaifenesin) Capsules DRUG DESCRIPTION Each Pseudovent™ 400 12-hour Capsule contains in combination: Pseudoephedrine hydrochloride...
Read More  |  Review This
Reviews Fentanyl Transdermal

Duragesic Drug Description DURAGESIC® (fentanyl transdermal system) FOR USE IN OPIOID-TOLERANT PATIENTS ONLY DURAGESIC® contains a high concentration of a potent Schedule II opioid agonist, fentanyl. Schedule II opioid substances...
Read More  |  Review This
Reviews Akten

Akten Drug Description Akten™ (lidocaine hydrochloride) Ophthalmic Gel 3.5% DRUG DESCRIPTION Akten™ (lidocaine hydrochloride ophthalmic gel) 3.5% is a sterile, preservative-free, single patient use ophthalmic gel preparation...
Read More  |  Review This
Reviews Reglan

Reglan Drug Description Reglan® (metoclopramide) Tablets, USP WARNING: TARDIVE DYSKINESIA Treatment with metoclopramide can cause tardive dyskinesia, a serious movement disorder that is often irreversible. The risk of developing...
Read More  |  Review This
Reviews KCL in D5W

KCL in D5W Drug Description Potassium Chloride in 5% Dextrose Injections USP DRUG DESCRIPTION (See chart below for quantitative information.) Potassium Chloride in 5% Dextrose Injections USP are sterile, nonpyrogenic and contain no bacteriostatic...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....